Drug Profile
NNC 0070 0002 0349
Alternative Names: NNC 0070-0002-0349Latest Information Update: 24 Sep 2014
Price :
$50
*
At a glance
- Originator Novo Nordisk
- Class Obesity therapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 24 Sep 2014 Discontinued - Phase-I for Obesity (In volunteers) in USA (SC)